Results 151 to 160 of about 78,155 (256)
Frailty Is an Independent Predictor of Mortality in Japanese Patients With Chronic Liver Disease: A Multicenter Retrospective Cohort Study
Hepatology Research, Volume 56, Issue 1, Page 70-77, January 2026.ABSTRACT Aim
Frailty is emerging as a prognostic factor in chronic liver disease (CLD). However, its clinical impact remains underexplored, particularly in Japan. This study aimed to evaluate the prognostic significance of frailty in Japanese patients with CLD.Shinji Unome, Mikita Oi, Yuki Utakata, Takao Miwa, Masashi Aiba, Tatsunori Hanai, Makoto Shiraki, Yasuhiro Kawashima, Naoki Katsumura, Masahito Shimizu +9 morewiley +1 more sourceDevelopment of a novel scoring system to determine the optimal timing of esophagogastroduodenoscopy following portosystemic shunt occlusion. [PDF]
PLoS OneNishimura T, Kirihara A, Egusa M, Nishiyama N, Fujioka T, Kawamoto D, Sasaki R, Tanabe N, Saeki I, Matsumoto T, Ishikawa T, Takami T. +11 moreeuropepmc +1 more sourceChronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood — Clinical, Virological and Immunological Long‐Term Follow‐Up
Journal of Viral Hepatitis, Volume 33, Issue 1, January 2026.ABSTRACT
Oncology patients receiving cytostatic therapy used to be at high risk of HBV infection when HBV screening measures were less reliable. Infections acquired under these conditions often persist, like those acquired perinatally or during early infancy.Thomas Baumgarten, Felix Lehmann, Tina Senff, Heiko Slanina, Christian G. Schüttler, Andreas Walker, Wolfram H. Gerlich, Reinald Repp, Jörg Timm, Dieter Glebe, Markus Metzler +10 morewiley +1 more sourceExpandable Constrained Transjugular Intrahepatic Portosystemic Shunt: An Individualised Approach for High‐Risk Patients?
Liver International, Volume 46, Issue 1, January 2026.ABSTRACT Background and Aims
A transjugular intrahepatic portosystemic shunt (TIPS) can effectively overcome portal hypertension, but is prevented by contraindications in a considerable proportion of patients. In this study, we investigated the option of a constrained TIPS (cTIPS) with reduced diameter for high‐risk patients.Hannah Rieland, Timo C. Meine, Anja Tiede, Jim B. Mauz, Heiner Wedemeyer, Jan B. Hinrichs, Frank K. Wacker, Benjamin Maasoumy +7 morewiley +1 more sourceAPSPGHAN Statement on Endoscopic Variceal Bleeding Hemostasis. [PDF]
Pediatr Gastroenterol Hepatol NutrUkarapol N, Poddar U, Lui TYS, Lee YJ, Lopez RN, Prachuapthunyachart S, Truong NV, Umetsu S, Sharma A, Yang YJ, Shahzadi N, Ng RT, Malik R, Vitug-Sales M, Arai K, Lee WS, Kim KM, Asia Pacific Society of Pediatric Gastroenterology, Hepatology and Nutrition (APSPGHAN) Endoscopy Scientific Subcommittee. +18 moreeuropepmc +1 more sourceNeoadjuvant Under‐Dilated TIPS: Expanding Surgeries for Extrahepatic Malignancies in Patients With Cirrhosis and CSPH
Liver International, Volume 46, Issue 1, January 2026.ABSTRACT Background & Aims
Portal hypertension is a major challenge in patients with cirrhosis requiring surgery. This study aimed to evaluate the efficacy of under‐dilated neoadjuvant transjugular intrahepatic portosystemic shunt (U.N‐TIPS) in enabling elective extrahepatic oncologic surgery in patients with cirrhosis and clinically significant portal Dario Saltini, Davide Roccarina, Marco Senzolo, Cristian Caporali, Fabrizio Fanelli, Marcello Bianchini, Federico Casari, Angelica Ingravallo, Silvia Aspite, Tomas Guasconi, Antonio Piscopo, Andrea Salome Velasco Mayorga, Barbara Catellani, Gian Piero Guerrini, Stefano Di Sandro, Fabio Staderini, Umberto Cillo, Fabrizio Di Benedetto, Antonio Colecchia, Fabio Marra, Patrizia Burra, Francesco Vizzutti, Filippo Schepis +22 morewiley +1 more source